Yunbin Chen 1, Meng Liu2, Dechun Zheng1, Qiuyuan Yue1, Xiaoxiao Zhang1, Hao Lin1, Weibo Chen 3, Queenie Chan4, Wang Ren1, and Xiangyi Liu1
1Fujian Provincial Cancer hospital, Fuzhou, China, People's Republic of, 2Fujian Provincial Cancer Hospital, Fuzhou, China, People's Republic of, 3Philips Healthcare, Shanghai, China, People's Republic of, 4Philips Healthcare, Hong Kong, China, People's Republic of
Synopsis
We assessed correlations between DCE-MRI quantitative parameters with
immunohistochemical labeling indices which reflect tumor hypoxia (HIF-1α), tumor angiogenesis (VEGF, MVD)
and tumor proliferation (Ki67) in nasopharyngeal carcinoma(NPC). We found that HIF-1α positive group was significantly correlated
with VEGF positive expression and MVD count respectively. Ktrans and Kepwas positively
associated with HIF-1α positive expression, VEGF positive expression and MVD
respectively .There were significantly positive correlations between
vp and the VEGF expression, MVD count respectively. However, there
were no significant relationship between the Ki67 expression and any DCE-MRI quantitative
parameters in our study.Purpose To assess correlations between dynamic contrast-enhanced MRI (DCE-MRI)
quantitative parameters with immunohistochemical
labeling indices which reflect tumor hypoxia (HIF-1α), tumor angiogenesis (VEGF, MVD) and tumor
proliferation (Ki67) in nasopharyngeal carcinoma(NPC), as well as the expression of HIF-1α,
VEGF, MVD and Ki67.
Methods Sixty-eight patients(55 males and 13 females; average age, 45 years; range,
16-70 years) with NPC received DCE-MRI and nasopharyngeal biopsy before treatment. We performed MRI examinations on a 3.0
tesla (Achieva TX, Philips Healthcare, Best,
The Netherlands) whole-body MR scanner
system equipped with parallel radio frequency transmission
using
a 16-channel neurovascular coil. We investigated quantitative kinetic parameters (Ktrans, Kep ,Ve
and Vp) by using DCE-Tool
based on extended Tofts’ model.HIF-1α, VEGF expression, MVD and Ki67 expression
were detected by immunohistochemistry(IHC) staining. MVD count was based on
Weidner method [1].The expression of Ki67 was the percentage of positive staining
cells. The expression of HIF-1α and VEGF were percentage multiplied by
intensity scores. Finally, the correlations were analyzed by Spearman’s rank
coefficient analysis. A p value <0.05 was considered statistical significance.
Results The representative
expressions of immunohistochemical
indices in NPC were shown
in Figure1.
HIF-1α positive group was significantly correlated
with VEGF positive expression and MVD count respectively (γ=0.514, γ=0.571; P < 0.001). MVD was statistically
correlated with the expression of VEGF positive group (γ=0.378). Ktrans was positively
associated with HIF-1α positive expression, VEGF positive expression and MVD
respectively (γ=0.600, γ=0.534, γ=0.668; P
<0.05).Kep was
positively associated with HIF-1α positive expression, VEGF positive expression
and MVD count respectively (γ=0.485, γ=0.365, γ=0.441; P <0.05). There were significantly positive correlations between
vp and the VEGF expression, MVD count respectively (γ=0.362, γ=0.366; P <0.05) (table 1). However, there
were no significant relationship between the Ki67 expression and any DCE-MRI quantitative
parameters in our study.
Discussions Previous studies found that HIF-1α and VEGF were
overexpression in NPC[2-3]. It was demonstrated that HIF-1α was a promoter to activate
the VEGF [4]. VEGF is one of the most important factor in regulating tumor
angiogenesis. Highly vascularized tumor tissue showed rapid enhancement after
contrast injection. Characteristics of tumor blood vessels lead to high
endothelial permeability and blood flow, which increased the DCE-MRI
quantitative parameters.
Conclusions Hypoxia plays a key role in the growth and treatment
of NPC. DCE-MRI quantitative parameters might be used to noninvasively assess
tumor hypoxia and tumor angiogenesis in NPC. This provides an opportunity of
applying DCE-MRI technique in early predicting treatment efficacy of NPC.
Acknowledgements
This study is partly supported by the Natural Science Foundation of Fujian Province (Grant No. 2012J01330) and partly supported by the National Clinical Key Specialty Construction Program and Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C. References
[1]. Foote RL, Weidner N, et al. Int J Radiat Oncol
Biol Phys.2005, 61(3): 745-753.
[2]. Chen YH. Med Oncol. 2014; 31(12): 304.
[3]. Guang-Wu H. Laryngoscope. 2000; 110(12):2066-9.
[4]. Forsythe
JA. Mol Cell Biol. 1996; 16(9): 4604–13.